Success Metrics

Completion Rate
0%(0/5)
Active Trials
1(17%)
Terminated
5(83%)

Phase Distribution

Ph phase_3
6
100%

Phase Distribution

0

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
6(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 5 finished

Non-Completion Rate

100.0%

5 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Terminated(5)

Detailed Status

Terminated5
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 36 (100.0%)

Trials by Status

terminated583%
recruiting117%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_3

Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.

NCT03388593
terminatedphase_3

Clinical Trial to Evaluate the Efficacy and Safety of Recombinant Human Neuregulin-1 for Subcutaneous Administration in Patients With Chronic Systolic Heart Failure

NCT01214096
terminatedphase_3

Study of Efficacy on NT-proBNP of Recombinant Human Neuregulin-1 in Chronic Heart Failure Patients

NCT01439789
terminatedphase_3

Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients

NCT01131637
terminatedphase_3

Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients

NCT01541202
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT03388593Phase 3

Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.

Recruiting
NCT01214096Phase 3

Clinical Trial to Evaluate the Efficacy and Safety of Recombinant Human Neuregulin-1 for Subcutaneous Administration in Patients With Chronic Systolic Heart Failure

Terminated
NCT01439789Phase 3

Study of Efficacy on NT-proBNP of Recombinant Human Neuregulin-1 in Chronic Heart Failure Patients

Terminated
NCT01131637Phase 3

Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients

Terminated
NCT01541202Phase 3

Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients

Terminated
NCT01439893Phase 3

Study of Efficacy on Cardiac Remodeling of Recombinant Human Neuregulin-1 in Stable Chronic Systolic Heart Failure Patients

Terminated

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6